We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is ASSERTIO THERAPEUTICS, INC (ASRT) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ASSERTIO THERAPEUTICS, INC (ASRT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of ASRT and the rest of the Medical group's stocks.
ASSERTIO THERAPEUTICS, INC is one of 905 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ASRT is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for ASRT's full-year earnings has moved 12% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ASRT has returned about 4% since the start of the calendar year. In comparison, Medical companies have returned an average of 2.48%. This means that ASSERTIO THERAPEUTICS, INC is performing better than its sector in terms of year-to-date returns.
Looking more specifically, ASRT belongs to the Medical - Drugs industry, a group that includes 175 individual stocks and currently sits at #110 in the Zacks Industry Rank. Stocks in this group have gained about 2.33% so far this year, so ASRT is performing better this group in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track ASRT. The stock will be looking to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is ASSERTIO THERAPEUTICS, INC (ASRT) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ASSERTIO THERAPEUTICS, INC (ASRT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of ASRT and the rest of the Medical group's stocks.
ASSERTIO THERAPEUTICS, INC is one of 905 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ASRT is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for ASRT's full-year earnings has moved 12% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ASRT has returned about 4% since the start of the calendar year. In comparison, Medical companies have returned an average of 2.48%. This means that ASSERTIO THERAPEUTICS, INC is performing better than its sector in terms of year-to-date returns.
Looking more specifically, ASRT belongs to the Medical - Drugs industry, a group that includes 175 individual stocks and currently sits at #110 in the Zacks Industry Rank. Stocks in this group have gained about 2.33% so far this year, so ASRT is performing better this group in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track ASRT. The stock will be looking to continue its solid performance.